valproic acid has been researched along with Neuronal Ceroid-Lipofuscinoses in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C; Lv, Y; Shi, M; Sun, L; Zhang, N | 1 |
| Larsen, EP; Ostergaard, JR | 1 |
| Duan, S; Han, Y; Li, X; Lou, H; Lu, Y; Zhen, X; Zhou, R; Zhu, L | 1 |
| Denecke, J; Johannsen, J; Nickel, M; Schulz, A | 1 |
| Talwar, D | 1 |
| Aberg, LE; Bäckman, M; Kirveskari, E; Santavuori, P | 1 |
1 trial(s) available for valproic acid and Neuronal Ceroid-Lipofuscinoses
| Article | Year |
|---|---|
Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Child; Child, Preschool; Clonazepam; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Female; Finland; Follow-Up Studies; Humans; Lamotrigine; Male; Neuronal Ceroid-Lipofuscinoses; Phenobarbital; Treatment Outcome; Triazines; Valproic Acid | 2000 |
5 other study(ies) available for valproic acid and Neuronal Ceroid-Lipofuscinoses
| Article | Year |
|---|---|
Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report.
Topics: Anticonvulsants; Atrophy; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Membrane Proteins; Mental Status and Dementia Tests; Mutation; Myoclonic Epilepsies, Progressive; Neuronal Ceroid-Lipofuscinoses; Occipital Lobe; Photosensitivity Disorders; Piracetam; Valproic Acid; Young Adult | 2018 |
Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Topics: Adolescent; Anticonvulsants; Brain Diseases; Carnitine; Drug Therapy, Combination; Female; Humans; Hyperammonemia; Male; Neuronal Ceroid-Lipofuscinoses; Valproic Acid; Vitamin B Complex; Young Adult | 2014 |
Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression.
Topics: Adaptation, Ocular; Animals; Antidepressive Agents; Bipolar Disorder; Cathepsin D; Corticosterone; Depression; Dextroamphetamine; Disease Models, Animal; Exploratory Behavior; Female; Food Preferences; Hyperkinesis; Lithium Chloride; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Ceroid-Lipofuscinoses; Sleep Wake Disorders; Swimming; Valproic Acid | 2015 |
Considering Valproate as a Risk Factor for Rapid Exacerbation of Complex Movement Disorder in Progressed Stages of Late-Infantile CLN2 Disease.
Topics: Anticonvulsants; Child; Child, Preschool; Consciousness Disorders; Creatine Kinase; Deprescriptions; Disease Progression; Epilepsy; Fever; Humans; Male; Movement Disorders; Neuronal Ceroid-Lipofuscinoses; Risk Factors; Tripeptidyl-Peptidase 1; Valproic Acid | 2016 |
Valproate-associated acute pancreatitis in a child with neuronal ceroid lipofuscinosis.
Topics: Acute Disease; Child; Female; Humans; Liver; Neuronal Ceroid-Lipofuscinoses; Pancreatitis; Seizures; Valproic Acid | 1994 |